Quality of life outcomes in two phase 3 trials of setmelanotide in patients with obesity due to LEPR or POMC deficiency

Orphanet Journal of Rare Diseases

February 5, 2022

10.1186/s13023-022-02186-z

Cited by 32

Related Papers

No related papers found

Powered by citation graph analysis